A Simple Mixed-Effects Modeling for the Precision of Automated Differential Cell Counters Using R

IF 2.8 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Karl S. M. Bisselou, Brett G. Hilbers, John N. Mensah
{"title":"A Simple Mixed-Effects Modeling for the Precision of Automated Differential Cell Counters Using R","authors":"Karl S. M. Bisselou,&nbsp;Brett G. Hilbers,&nbsp;John N. Mensah","doi":"10.1111/cts.70254","DOIUrl":null,"url":null,"abstract":"<p>To register their device, manufacturers of automated differential cell counters (ADCC) are required to demonstrate satisfactory precision that meets regulatory standards such as those in 21 CFR 864.5220 in the United States. Mixed-effects models can be used for the estimation of variance components from a range of factors (operators, days, reagent lots, etc.) to characterize the “within-laboratory” or “across laboratories” analytical error associated with ADCCs for a variety of samples representing a plethora of measurand intervals. However, this task can be daunting and time-consuming due to the increasing complexity of the number of blood-associated parameters reported by those devices and the iterative calculations over numerous factors. In this paper, we propose a simple-to-follow <i>R</i> algorithm that overcomes these challenges and provides a comprehensive and effective estimation of variance components in a regulatory-ready reporting format.</p>","PeriodicalId":50610,"journal":{"name":"Cts-Clinical and Translational Science","volume":"18 5","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cts.70254","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cts-Clinical and Translational Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cts.70254","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

To register their device, manufacturers of automated differential cell counters (ADCC) are required to demonstrate satisfactory precision that meets regulatory standards such as those in 21 CFR 864.5220 in the United States. Mixed-effects models can be used for the estimation of variance components from a range of factors (operators, days, reagent lots, etc.) to characterize the “within-laboratory” or “across laboratories” analytical error associated with ADCCs for a variety of samples representing a plethora of measurand intervals. However, this task can be daunting and time-consuming due to the increasing complexity of the number of blood-associated parameters reported by those devices and the iterative calculations over numerous factors. In this paper, we propose a simple-to-follow R algorithm that overcomes these challenges and provides a comprehensive and effective estimation of variance components in a regulatory-ready reporting format.

Abstract Image

基于R的自动差分单元计数器精度的简单混合效应建模
为了注册他们的设备,自动差分细胞计数器(ADCC)的制造商需要证明令人满意的精度,符合美国21 CFR 864.5220的监管标准。混合效应模型可用于估计来自一系列因素(操作员、天数、试剂批次等)的方差成分,以表征与adcc相关的“实验室内”或“跨实验室”分析误差,用于代表过多测量间隔的各种样品。然而,由于这些设备报告的血液相关参数数量越来越复杂,并且需要对许多因素进行迭代计算,因此这项任务可能令人生畏且耗时。在本文中,我们提出了一种简单易用的R算法,克服了这些挑战,并以监管就绪的报告格式提供了对方差成分的全面有效估计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cts-Clinical and Translational Science
Cts-Clinical and Translational Science 医学-医学:研究与实验
CiteScore
6.70
自引率
2.60%
发文量
234
审稿时长
6-12 weeks
期刊介绍: Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信